Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients

The aim of the present study is to assess the disease profile, outcome and prognostic factors in patients treated with surgery combined with radiotherapy (RT), with or without chemotherapy (CXT), for soft-tissue sarcoma (STS) in a multidisciplinary setting. One hundred and sixty-four patients with S...

Full description

Bibliographic Details
Main Authors: Ling Cai, René-Olivier Mirimanoff, Elyazid Mouhsine, Louis Guillou, Pierre-Francois Leyvraz, Serge Leyvraz, Beatrice Gay, Oscar Matzinger, Mahmut Ozsahin, Abderrahim Zouhair
Format: Article
Language:English
Published: SAGE Publishing 2013-10-01
Series:Rare Tumors
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/rt/article/view/4799
_version_ 1828771918353793024
author Ling Cai
René-Olivier Mirimanoff
Elyazid Mouhsine
Louis Guillou
Pierre-Francois Leyvraz
Serge Leyvraz
Beatrice Gay
Oscar Matzinger
Mahmut Ozsahin
Abderrahim Zouhair
author_facet Ling Cai
René-Olivier Mirimanoff
Elyazid Mouhsine
Louis Guillou
Pierre-Francois Leyvraz
Serge Leyvraz
Beatrice Gay
Oscar Matzinger
Mahmut Ozsahin
Abderrahim Zouhair
author_sort Ling Cai
collection DOAJ
description The aim of the present study is to assess the disease profile, outcome and prognostic factors in patients treated with surgery combined with radiotherapy (RT), with or without chemotherapy (CXT), for soft-tissue sarcoma (STS) in a multidisciplinary setting. One hundred and sixty-four patients with STS treated between 1980 and 2010 at the <em>Centre Hospitalier Universitaire Vaudois</em> were enrolled in this retrospective study. Seventy-six percent of patients underwent postoperative RT with (24%), or without (52%) CXT, 15% preoperative RT with (5%), or without (10%) CXT, surgery alone (7%), or RT alone (2%) with or without CXT. The median follow-up was 60 months (range 6-292). Local failure was observed in 18%, and distant failure in 21% of the patients. Overall survival (OS), disease-free survival (DFS), local control (LC) and distant metastases-free survival (DMFS) were 88%, 68%, 83%, and 79% at 5 years, and 80%, 56%, 76%, and 69% at 10 years, respectively. In univariate analyses, favorable prognostic factors for OS, DFS, and DMFS were tumor size 6 cm or less, World Health Organization (WHO)/Zubrod score 0, and stage 2 or less. Age and superficial tumors were favorable only for OS and DMFS respectively. STS involving the extremities had a better outcome regarding DFS and LC. Histological grade 2 or less was favorable for DFS, DMFS, and LC. Radical surgery was associated with better LC and DMFS. RT dose more than 60 Gy was favorable for OS, DFS, and LC. In multivariate analyses, independent factors were age for OS; tumor size for OS, DFS and DMFS; WHO/Zubrod score for OS, DFS and LC; hemoglobin level for DFS; site for DFS and LC; tumor depth for DMFS; histological grade for DFS and LC; surgical procedure for LC and DMFS; and RT dose for OS. This study confirms that in a multidisciplinary setting, STS have a fairly good prognosis. A number of prognostic and predictive factors, including the role of surgery combined with RT, were identified. Regarding RT, a dose of more than 60 Gy was associated with a better outcome, at the price of a higher toxicity. We could not demonstrate a superiority of preoperative RT over postoperative RT.
first_indexed 2024-12-11T14:34:19Z
format Article
id doaj.art-7bc0e73db3a14bf6a75d70c181aff334
institution Directory Open Access Journal
issn 2036-3605
2036-3613
language English
last_indexed 2024-12-11T14:34:19Z
publishDate 2013-10-01
publisher SAGE Publishing
record_format Article
series Rare Tumors
spelling doaj.art-7bc0e73db3a14bf6a75d70c181aff3342022-12-22T01:02:16ZengSAGE PublishingRare Tumors2036-36052036-36132013-10-0154e55e5510.4081/rt.2013.e552647Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patientsLing Cai0René-Olivier Mirimanoff1Elyazid Mouhsine2Louis Guillou3Pierre-Francois Leyvraz4Serge Leyvraz5Beatrice Gay6Oscar Matzinger7Mahmut Ozsahin8Abderrahim Zouhair9Department of Radiation Oncology, Vaud University Hospital Center, LausanneDepartment of Radiation Oncology, Vaud University Hospital Center, LausanneDepartment of Orthopedic Surgery, Vaud University Hospital Center, LausanneDepartment of Pathology, Vaud University Hospital Center, LausanneDepartment of Orthopedic Surgery, Vaud University Hospital Center, LausanneDepartment of Medical Oncology, Vaud University Hospital Center, LausanneDepartment of Medical Oncology, Vaud University Hospital Center, LausanneDepartment of Radiation Oncology, Vaud University Hospital Center, LausanneDepartment of Radiation Oncology, Vaud University Hospital Center, LausanneDepartment of Radiation Oncology, Vaud University Hospital Center, LausanneThe aim of the present study is to assess the disease profile, outcome and prognostic factors in patients treated with surgery combined with radiotherapy (RT), with or without chemotherapy (CXT), for soft-tissue sarcoma (STS) in a multidisciplinary setting. One hundred and sixty-four patients with STS treated between 1980 and 2010 at the <em>Centre Hospitalier Universitaire Vaudois</em> were enrolled in this retrospective study. Seventy-six percent of patients underwent postoperative RT with (24%), or without (52%) CXT, 15% preoperative RT with (5%), or without (10%) CXT, surgery alone (7%), or RT alone (2%) with or without CXT. The median follow-up was 60 months (range 6-292). Local failure was observed in 18%, and distant failure in 21% of the patients. Overall survival (OS), disease-free survival (DFS), local control (LC) and distant metastases-free survival (DMFS) were 88%, 68%, 83%, and 79% at 5 years, and 80%, 56%, 76%, and 69% at 10 years, respectively. In univariate analyses, favorable prognostic factors for OS, DFS, and DMFS were tumor size 6 cm or less, World Health Organization (WHO)/Zubrod score 0, and stage 2 or less. Age and superficial tumors were favorable only for OS and DMFS respectively. STS involving the extremities had a better outcome regarding DFS and LC. Histological grade 2 or less was favorable for DFS, DMFS, and LC. Radical surgery was associated with better LC and DMFS. RT dose more than 60 Gy was favorable for OS, DFS, and LC. In multivariate analyses, independent factors were age for OS; tumor size for OS, DFS and DMFS; WHO/Zubrod score for OS, DFS and LC; hemoglobin level for DFS; site for DFS and LC; tumor depth for DMFS; histological grade for DFS and LC; surgical procedure for LC and DMFS; and RT dose for OS. This study confirms that in a multidisciplinary setting, STS have a fairly good prognosis. A number of prognostic and predictive factors, including the role of surgery combined with RT, were identified. Regarding RT, a dose of more than 60 Gy was associated with a better outcome, at the price of a higher toxicity. We could not demonstrate a superiority of preoperative RT over postoperative RT.http://www.pagepress.org/journals/index.php/rt/article/view/4799soft-tissue sarcoma, radiotherapy, preoperative, postoperative, complications, prognostic factors
spellingShingle Ling Cai
René-Olivier Mirimanoff
Elyazid Mouhsine
Louis Guillou
Pierre-Francois Leyvraz
Serge Leyvraz
Beatrice Gay
Oscar Matzinger
Mahmut Ozsahin
Abderrahim Zouhair
Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
Rare Tumors
soft-tissue sarcoma, radiotherapy, preoperative, postoperative, complications, prognostic factors
title Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
title_full Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
title_fullStr Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
title_full_unstemmed Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
title_short Prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy: a retrospective single-center study on 164 patients
title_sort prognostic factors in adult soft tissue sarcoma treated with surgery combined with radiotherapy a retrospective single center study on 164 patients
topic soft-tissue sarcoma, radiotherapy, preoperative, postoperative, complications, prognostic factors
url http://www.pagepress.org/journals/index.php/rt/article/view/4799
work_keys_str_mv AT lingcai prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT reneoliviermirimanoff prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT elyazidmouhsine prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT louisguillou prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT pierrefrancoisleyvraz prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT sergeleyvraz prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT beatricegay prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT oscarmatzinger prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT mahmutozsahin prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients
AT abderrahimzouhair prognosticfactorsinadultsofttissuesarcomatreatedwithsurgerycombinedwithradiotherapyaretrospectivesinglecenterstudyon164patients